TY  - GEN
AU  - Cuffe,M S
AU  - Califf,R M
AU  - Adams,K F
AU  - Bourge,R C
AU  - Colucci,W
AU  - Massie,B
AU  - O'Connor,C M
AU  - Pina,I
AU  - Quigg,R
AU  - Silver,M
AU  - Robinson,L A
AU  - Leimberger,J D
AU  - Gheorghiade,M
TI  - Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure
SN  - 0002-8703
PY  - 2000///0127
KW  - Adolescent
KW  - Cost-Benefit Analysis
KW  - Female
KW  - Heart Failure
KW  - drug therapy
KW  - Hospital Mortality
KW  - Humans
KW  - Injections, Intravenous
KW  - Length of Stay
KW  - Male
KW  - Milrinone
KW  - administration & dosage
KW  - Phosphodiesterase Inhibitors
KW  - Prospective Studies
KW  - Quality of Life
KW  - Survival Rate
KW  - Treatment Outcome
KW  - United States
KW  - epidemiology
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0002-8703(00)90303-x
ER  -